CircMAN1A2 promotes vasculogenic mimicry of nasopharyngeal carcinoma cells through upregulating ERBB2 via sponging miR-940

Author:

MO HUAQING,SHEN JINGYI,ZHONG YUXIAO,CHEN ZENAN,WU TONG,LV YANYU,XIE YANYAN,HAO YANRONG

Publisher

Computers, Materials and Continua (Tech Science Press)

Subject

Cancer Research,Oncology,General Medicine

Reference51 articles.

1. Metastasis of nasopharyngeal carcinoma: What we know and do not know;Guo;Visualized Cancer Medicine,2021

2. Emerging therapeutic targets for nasopharyngeal carcinoma: Opportunities and challenges;Baloche;Expert Opinion on Therapeutic Targets,2020

3. Expression and clinical significance of microvessel density and its association with TWIST in nasopharyngeal carcinoma;Zhuo;International Journal of Clinical and Experimental Medicine,2015

4. Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): A phase 2 multi-institutional trial;Lee;The Lancet Oncology,2012

5. Long-term efficacy and adverse reactions of IMRT combined with Endostar versus IMRT combined with chemotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study;Chen;Annals of Palliative Medicine,2021

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3